Carson Wealth (CWM LLC)’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$254 Hold
146
﹤0.01% 5514
2025
Q4
$0 Buy
+146
New +$322 ﹤0.01% 5494
2025
Q3
Sell
-5,532
Closed -$11K 5400
2025
Q2
$11K Buy
5,532
+570
+11% +$1.09K ﹤0.01% 4242
2025
Q1
$8K Buy
4,962
+3,228
+186% +$6.48K ﹤0.01% 4218
2024
Q4
$3K Buy
+1,734
New +$7.67K ﹤0.01% 4415
2023
Q1
Sell
-9
Closed 4186
2022
Q4
$0 Buy
+9
New +$204 ﹤0.01% 4100
2022
Q2
Sell
-30
Closed -$1K 3937
2022
Q1
$1K Hold
30
﹤0.01% 3358
2021
Q4
$2K Buy
+30
New +$2.4K ﹤0.01% 3130
2021
Q2
$3K Hold
30
﹤0.01% 2528
2021
Q1
$3K Hold
30
﹤0.01% 2528
2020
Q4
$3K Hold
30
﹤0.01% 2528
2020
Q3
$3K Hold
30
﹤0.01% 2528
2020
Q2
$3K Hold
30
﹤0.01% 2527
2020
Q1
$3K Hold
30
﹤0.01% 2526
2019
Q4
$3K Hold
30
﹤0.01% 2525
2019
Q3
$3K Hold
30
﹤0.01% 2525
2019
Q2
$3K Hold
30
﹤0.01% 2525
2019
Q1
$3K Sell
30
-220
-88% -$11.1K ﹤0.01% 2525
2018
Q4
$12K Hold
250
﹤0.01% 1272
2018
Q3
$17K Hold
250
﹤0.01% 992
2018
Q2
$12K Buy
+250
New +$13.8K ﹤0.01% 952

Other funds holding INO

Carson Wealth (CWM LLC)'s INO Position: Q1 2026 in Review

Carson Wealth (CWM LLC) held its Inovio Pharmaceuticals (INO) position steady in Q1 2026 at 146 shares worth $254. The position accounts for ﹤0.01% of the portfolio, ranked #5514.

Carson Wealth (CWM LLC) first reported a position in INO in Q2 2018 and has held it in 21 quarters since. The position peaked at $17K in Q3 2018. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

  • Carson Wealth (CWM LLC) held 146 shares of Inovio Pharmaceuticals worth $254 as of Q1 2026.
  • Carson Wealth (CWM LLC) left its Inovio Pharmaceuticals share count unchanged in Q1 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5514 holding.
  • Carson Wealth (CWM LLC) first reported a position in Inovio Pharmaceuticals in Q2 2018 and has held it in 21 quarters since.
  • Carson Wealth (CWM LLC)'s Inovio Pharmaceuticals position peaked at $17K in Q3 2018.
  • 100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.